Name

TEE

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for TEE

Name

Alternate Names

Emcyt
Emcyt IV
Estracyt
Estramustine phosphate disodium
Leo 275
Leo275
Ro 21-8837
Ro 21-8837/001
Ro 218837
Ro 22-2296/000
Ro 222296/000
Ro-218837

Abbreviations

None

Category

Chemotherapy

Subcategory

Antimicrotubule agent

NSC Number

089199
089201
89199

Primary Site

Prostate cancer

Histology

None

Remarks

A nitrogen mustard antineoplastic agent. Chemotoxic hormone. An antineoplastic agent consisting of estradiol joined to nornitrogen mustard by a carbamate link, phosphorylated to make it water soluble; used for palliative treatment of metastatic or progressive carcinoma of the prostate. Single agent or combined with taxane for HRPC. FDA approved use on prostate cancer. Pharamcia.

Coding

This drug should be coded

Name

Alternate Names

Dom-Etoposide
Epipodophyllotoxin derivative
Epipodophyllotoxin ethylidene gluco-pyranoside
Eposine
Ethylidene-Lignan P
Etopophos
Podophyllotoxin derivative
Vepesid
VP 16-213
VP-16
VP-16213
Toposar

Abbreviations

EPEG
VP-16
VP-16-213

Category

Chemotherapy

Subcategory

Epipodophyllotoxin, topoisomerase II inhibitor
Plant alkaloid

NSC Number

141540

Primary Site

Gastric cancer
Hodgkins lymphoma
Lung cancer (NSCLC, SCLC)
Non-Hodgkin lymphoma
testicular cancer (Germ cell tumors)

Histology

None

Remarks

Plant alkaloid. FDA approved use on small-cell lung cancer, testicular cancer.

Coding

This drug should be coded

Name

Alternate Names

BMS-181339-01
BMY-45622
Taxol

Abbreviations

None

Category

Chemotherapy

Subcategory

Mitotic inhibitor
plant alkaloid
Taxane

NSC Number

125973
673089

Primary Site

breast
Gastric
head & neck cancer
Kaposi's sarcoma
non-small cell lung cancers
ovarian

Histology

None

Remarks

Phase I (gastric) FDA approved uses on breast, ovarian, non-small cell lung cancers, and Kaposi's sarcoma. Bristol-Myers Squibb.

Coding

This drug should be coded
Glossary